- Article metrics
- Last updated: Fri, 10 Oct 2025 20:54:22 Z
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Access & Citations
-
- 82k
- Article Accesses
-
- 2717
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
Online attention
- 27 tweeters
- 7 blogs
- 4 Facebook pages
- 3 news outlets
- 1 F1000
- 2 Wikipedia page
- 1697 Mendeley
- 1 Citeulike
This article is in the 98th percentile (ranked 3,249th) of the 306,756 tracked articles of a similar age in all journals and the 96th percentile (ranked 4th) of the 105 tracked articles of a similar age in Nature Medicine
View more on Altmetric
Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.
Mentions in news and blogs
-
Kill the Tumor But Spare the Platelets!
ChemistryViews -
An Unexpected Halt In Multiple Myeloma For Venetoclax
Seeking Alpha -
ASH 2012: ABT-199 shows promise in CLL and MCL
Biotech Strategy Blog -
ASH 2012: ABT-199 shows promise in CLL and MCL
Biotech Strategy Blog -
ABT-199 Clinical Trial Suspended
In the Pipeline -
ABT-199 Clinical Trial Suspended (Updated)
In the Pipeline -
Drug Combination Improves Outlook for Some Patients with Chronic Lymphocytic Leukemia
Cancer Currents: An NCI Cancer Research Blog -
An Unexpected Halt in Multiple Myeloma for Venetoclax
In the Pipeline
This list highlights individual mainstream news articles and blogs that cite the article. Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media. Altmetric are responsible for the curation of this list and provide updates hourly.